Preclinical Alzheimer’s disease

Preclinical Alzheimer’s disease refers to a stage where brain changes associated with Alzheimer’s are occurring, but the person shows no noticeable memory or thinking problems. During this phase, abnormal protein buildup begins in the brain, but cognitive functions remain intact. Detecting these changes early is challenging, but it offers a window for potential interventions before symptoms emerge. Understanding preclinical Alzheimer’s helps researchers develop strategies to prevent or delay the progression to more severe stages of the disease.